Memory completes enrollment in phase II trial of MEM-3454 in CI associated with schizophrenia Nov. 21, 2008
Positive results emerge from phase III ALO-01 study in patients with osteoarthritis pain Nov. 21, 2008
Potent antihyperalgesia and good safety profile with novel delta opioid receptor agonist Nov. 20, 2008
RSS